Viewing Study NCT03484520


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-01-17 @ 12:58 AM
Study NCT ID: NCT03484520
Status: TERMINATED
Last Update Posted: 2022-12-30
First Post: 2018-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M16-183
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View